Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Chemioterapia skojarzona, bewacyzumab i/lub atezolizumab w leczeniu pacjentów z niedoborem naprawy błędnego sparowania DNA z przerzutowym rakiem jelita grubego, badanie COMMIT

11 listopada 2026 zaktualizowane przez: National Cancer Institute (NCI)

Badanie COMMIT na raka jelita grubego z przerzutami dMMR/MSI-H Immuno-Therapy: Randomizowane badanie III fazy dotyczące kombinacji mFOLFOX6/Bewacyzumab/Atezolizumab w porównaniu z Atezolizumabem w monoterapii w leczeniu pierwszego rzutu pacjentów z niedoborem naprawy niezgodności DNA (dMMR)/mikrosatelitarną Niestabilność-wysoka (MSI-H) przerzutowy rak jelita grubego

This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as fluorouracil, oxaliplatin, and leucovorin calcium, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of the tumor. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving combination chemotherapy, bevacizumab, and atezolizumab may work better in treating patients with colorectal cancer.

Przegląd badań

Szczegółowy opis

PRIMARY OBJECTIVE:

I. To determine the efficacy, based on progression-free survival (PFS), of fluorouracil, oxaliplatin, and leucovorin calcium (modified [m]FOLFOX6)/bevacizumab plus atezolizumab (combination) as compared to single agent atezolizumab.

SECONDARY OBJECTIVES:

I. To compare the overall survival. II. To compare the objective response rates (ORR) per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1.

III. To determine the safety profiles of single agent atezolizumab and the combination of mFOLFOX6/bevacizumab/atezolizumab in patients with mismatch-repair deficient (dMMR)/microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC).

IV. To determine the duration of response. V. To determine the duration of stable disease. VI. To determine the rate of progression-free survival (PFS) at 12 months. VII. To evaluate the disease control rate (complete response [CR] + partial response [PR] + stable disease [SD]) at 12 months.

TRANSLATIONAL OBJECTIVE:

I. To bank tissue and blood samples for other future correlative studies from patients enrolled on the study.

OUTLINE: Patients are randomized to 1 of 3 arms.

ARM I (CLOSED TO ACCRUAL 6/4/2020): Patients receive bevacizumab intravenously (IV) over 30-90 minutes on day 1, oxaliplatin IV over 2 hours on day 1 of cycles 1-10, leucovorin calcium IV over 2 hours on day 1, and fluorouracil IV over 46-48 hours on days 1 and 2. Treatment with oxaliplatin repeats every 2 weeks for up to 10 cycles in the absence of disease progression or unacceptable toxicity. Treatment of bevacizumab, leucovorin calcium, and fluorouracil repeat every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo computed tomography (CT) with or without positron emission tomography (PET) or magnetic resonance imaging (MRI) throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial.

ARM II: Patients receive atezolizumab IV over 30-60 minutes on day 1. Treatment repeats every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial.

ARM III: Patients receive atezolizumab IV over 30-60 minutes on day 1. Treatment repeats every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients also receive bevacizumab IV over 30-90 minutes on day 1, oxaliplatin IV over 2 hours on day 1 cycles 1-10, leucovorin calcium IV over 2 hours on day 1, and fluorouracil IV over 46-48 hours on day 1. Treatment with oxaliplatin repeats every 2 weeks for up to 10 cycles in the absence of disease progression or unacceptable toxicity. Treatment of bevacizumab, leucovorin calcium, and fluorouracil repeat every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial.

After completion of study treatment, patients are followed up every 8 weeks for 18 months, and then every 12 weeks for up to 5 years.

Typ studiów

Interwencyjne

Zapisy (Szacowany)

120

Faza

  • Faza 3

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

    • Arizona
      • Kingman, Arizona, Stany Zjednoczone, 86401
        • Kingman Regional Medical Center
    • Arkansas
      • Jonesboro, Arkansas, Stany Zjednoczone, 72401
        • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
    • California
      • Anaheim, California, Stany Zjednoczone, 92806
        • Kaiser Permanente-Anaheim
      • Baldwin Park, California, Stany Zjednoczone, 91706
        • Kaiser Permanente-Baldwin Park
      • Bellflower, California, Stany Zjednoczone, 90706
        • Kaiser Permanente-Bellflower
      • Berkeley, California, Stany Zjednoczone, 94704
        • Alta Bates Summit Medical Center-Herrick Campus
      • Concord, California, Stany Zjednoczone, 94520
        • John Muir Medical Center-Concord
      • Fontana, California, Stany Zjednoczone, 92335
        • Kaiser Permanente-Fontana
      • Harbor City, California, Stany Zjednoczone, 90710
        • Kaiser Permanente South Bay
      • Irvine, California, Stany Zjednoczone, 92618
        • Kaiser Permanente-Irvine
      • Los Angeles, California, Stany Zjednoczone, 90027
        • Kaiser Permanente Los Angeles Medical Center
      • Los Angeles, California, Stany Zjednoczone, 90034
        • Kaiser Permanente West Los Angeles
      • Marysville, California, Stany Zjednoczone, 95901
        • Fremont - Rideout Cancer Center
      • Modesto, California, Stany Zjednoczone, 95355
        • Memorial Medical Center
      • Ontario, California, Stany Zjednoczone, 91761
        • Kaiser Permanente-Ontario
      • Orange, California, Stany Zjednoczone, 92868
        • UC Irvine Health/Chao Family Comprehensive Cancer Center
      • Orange, California, Stany Zjednoczone, 92868
        • Saint Joseph Hospital - Orange
      • Panorama City, California, Stany Zjednoczone, 91402
        • Kaiser Permanente - Panorama City
      • Riverside, California, Stany Zjednoczone, 92505
        • Kaiser Permanente-Riverside
      • Sacramento, California, Stany Zjednoczone, 95816
        • Sutter Medical Center Sacramento
      • Sacramento, California, Stany Zjednoczone, 95817
        • University of California Davis Comprehensive Cancer Center
      • Salinas, California, Stany Zjednoczone, 93901
        • Salinas Valley Memorial
      • San Diego, California, Stany Zjednoczone, 92120
        • Kaiser Permanente-San Diego Zion
      • San Diego, California, Stany Zjednoczone, 92108
        • Kaiser Permanente-Rio San Diego
      • San Marcos, California, Stany Zjednoczone, 92078
        • Kaiser Permanente-San Marcos
      • Walnut Creek, California, Stany Zjednoczone, 94598
        • John Muir Medical Center-Walnut Creek
      • Whittier, California, Stany Zjednoczone, 90602
        • Presbyterian Intercommunity Hospital
      • Woodland Hills, California, Stany Zjednoczone, 91367
        • Kaiser Permanente-Woodland Hills
    • Colorado
      • Aurora, Colorado, Stany Zjednoczone, 80012
        • Rocky Mountain Cancer Centers-Aurora
      • Aurora, Colorado, Stany Zjednoczone, 80045
        • UCHealth University of Colorado Hospital
      • Boulder, Colorado, Stany Zjednoczone, 80303
        • Boulder Community Foothills Hospital
      • Boulder, Colorado, Stany Zjednoczone, 80304
        • Rocky Mountain Cancer Centers-Boulder
      • Colorado Springs, Colorado, Stany Zjednoczone, 80907
        • Penrose-Saint Francis Healthcare
      • Colorado Springs, Colorado, Stany Zjednoczone, 80909
        • UCHealth Memorial Hospital Central
      • Colorado Springs, Colorado, Stany Zjednoczone, 80920
        • Memorial Hospital North
      • Denver, Colorado, Stany Zjednoczone, 80218
        • Rocky Mountain Cancer Centers-Midtown
      • Denver, Colorado, Stany Zjednoczone, 80220
        • Rocky Mountain Cancer Centers-Rose
      • Denver, Colorado, Stany Zjednoczone, 80204
        • Denver Health Medical Center
      • Denver, Colorado, Stany Zjednoczone, 80206
        • National Jewish Health-Main Campus
      • Denver, Colorado, Stany Zjednoczone, 80218
        • Saint Joseph Hospital - Cancer Centers of Colorado
      • Denver, Colorado, Stany Zjednoczone, 80210
        • AdventHealth Porter
      • Englewood, Colorado, Stany Zjednoczone, 80113
        • Mountain Blue Cancer Care Center - Swedish
      • Englewood, Colorado, Stany Zjednoczone, 80113
        • Swedish Medical Center
      • Fort Collins, Colorado, Stany Zjednoczone, 80524
        • Poudre Valley Hospital
      • Fort Collins, Colorado, Stany Zjednoczone, 80528
        • Cancer Care and Hematology-Fort Collins
      • Golden, Colorado, Stany Zjednoczone, 80401
        • National Jewish Health-Western Hematology Oncology
      • Greeley, Colorado, Stany Zjednoczone, 80631
        • UCHealth Greeley Hospital
      • Greeley, Colorado, Stany Zjednoczone, 80631
        • Banner North Colorado Medical Center
      • Littleton, Colorado, Stany Zjednoczone, 80120
        • Rocky Mountain Cancer Centers-Littleton
      • Lone Tree, Colorado, Stany Zjednoczone, 80124
        • Rocky Mountain Cancer Centers-Sky Ridge
      • Loveland, Colorado, Stany Zjednoczone, 80538
        • Medical Center of the Rockies
      • Loveland, Colorado, Stany Zjednoczone, 80539
        • Banner North Colorado Medical Center - Loveland Campus
      • Thornton, Colorado, Stany Zjednoczone, 80260
        • National Jewish Health-Northern Hematology Oncology
      • Wheat Ridge, Colorado, Stany Zjednoczone, 80401
        • Intermountain Health Lutheran Hospital
    • Connecticut
      • Danbury, Connecticut, Stany Zjednoczone, 06810
        • Danbury Hospital
      • Hartford, Connecticut, Stany Zjednoczone, 06102
        • Hartford Hospital
      • Meriden, Connecticut, Stany Zjednoczone, 06451
        • Midstate Medical Center
      • New Britain, Connecticut, Stany Zjednoczone, 06050
        • The Hospital of Central Connecticut
      • Norwich, Connecticut, Stany Zjednoczone, 06360
        • William Backus Hospital
    • Delaware
      • Millville, Delaware, Stany Zjednoczone, 19967
        • Beebe South Coastal Health Campus
      • Newark, Delaware, Stany Zjednoczone, 19713
        • Helen F Graham Cancer Center
      • Newark, Delaware, Stany Zjednoczone, 19713
        • Medical Oncology Hematology Consultants PA
      • Rehoboth Beach, Delaware, Stany Zjednoczone, 19971
        • Beebe Health Campus
    • District of Columbia
      • Washington D.C., District of Columbia, Stany Zjednoczone, 20002
        • Kaiser Permanente-Capitol Hill Medical Center
    • Florida
      • Fort Lauderdale, Florida, Stany Zjednoczone, 33316
        • Broward Health Medical Center
      • Fort Myers, Florida, Stany Zjednoczone, 33905
        • Regional Cancer Center-Lee Memorial Health System
      • Gainesville, Florida, Stany Zjednoczone, 32610
        • UF Health Cancer Institute - Gainesville
      • Jacksonville, Florida, Stany Zjednoczone, 32207
        • Baptist MD Anderson Cancer Center
      • Orlando, Florida, Stany Zjednoczone, 32803
        • AdventHealth Orlando
    • Georgia
      • Albany, Georgia, Stany Zjednoczone, 31701
        • Phoebe Putney Memorial Hospital
      • Athens, Georgia, Stany Zjednoczone, 30607
        • University Cancer and Blood Center LLC
      • Augusta, Georgia, Stany Zjednoczone, 30912
        • Augusta University Medical Center
      • Augusta, Georgia, Stany Zjednoczone, 30901
        • Augusta Oncology Associates PC-D'Antignac
      • Augusta, Georgia, Stany Zjednoczone, 30909
        • Augusta Oncology Associates PC-Wheeler
      • Newnan, Georgia, Stany Zjednoczone, 30265
        • CTCA at Southeastern Regional Medical Center
    • Idaho
      • Boise, Idaho, Stany Zjednoczone, 83706
        • Saint Alphonsus Cancer Care Center-Boise
      • Boise, Idaho, Stany Zjednoczone, 83712
        • Saint Luke's Cancer Institute - Boise
      • Caldwell, Idaho, Stany Zjednoczone, 83605
        • Saint Alphonsus Cancer Care Center-Caldwell
      • Coeur d'Alene, Idaho, Stany Zjednoczone, 83814
        • Kootenai Health - Coeur d'Alene
      • Fruitland, Idaho, Stany Zjednoczone, 83619
        • Saint Luke's Cancer Institute - Fruitland
      • Meridian, Idaho, Stany Zjednoczone, 83642
        • Saint Luke's Cancer Institute - Meridian
      • Nampa, Idaho, Stany Zjednoczone, 83687
        • Saint Alphonsus Cancer Care Center-Nampa
      • Nampa, Idaho, Stany Zjednoczone, 83687
        • Saint Luke's Cancer Institute - Nampa
      • Post Falls, Idaho, Stany Zjednoczone, 83854
        • Kootenai Clinic Cancer Services - Post Falls
      • Sandpoint, Idaho, Stany Zjednoczone, 83864
        • Kootenai Clinic Cancer Services - Sandpoint
      • Twin Falls, Idaho, Stany Zjednoczone, 83301
        • Saint Luke's Cancer Institute - Twin Falls
    • Illinois
      • Bloomington, Illinois, Stany Zjednoczone, 61704
        • Illinois CancerCare-Bloomington
      • Canton, Illinois, Stany Zjednoczone, 61520
        • Illinois CancerCare-Canton
      • Carthage, Illinois, Stany Zjednoczone, 62321
        • Illinois CancerCare-Carthage
      • Centralia, Illinois, Stany Zjednoczone, 62801
        • Centralia Oncology Clinic
      • Chicago, Illinois, Stany Zjednoczone, 60612
        • University of Illinois
      • Chicago, Illinois, Stany Zjednoczone, 60612
        • Rush MD Anderson Cancer Center
      • Danville, Illinois, Stany Zjednoczone, 61832
        • Carle at The Riverfront
      • Decatur, Illinois, Stany Zjednoczone, 62526
        • Cancer Care Specialists of Illinois - Decatur
      • Dixon, Illinois, Stany Zjednoczone, 61021
        • Illinois CancerCare-Dixon
      • Effingham, Illinois, Stany Zjednoczone, 62401
        • Crossroads Cancer Center
      • Effingham, Illinois, Stany Zjednoczone, 62401
        • Carle Physician Group-Effingham
      • Eureka, Illinois, Stany Zjednoczone, 61530
        • Illinois CancerCare-Eureka
      • Evanston, Illinois, Stany Zjednoczone, 60201
        • NorthShore University HealthSystem-Evanston Hospital
      • Galesburg, Illinois, Stany Zjednoczone, 61401
        • Illinois CancerCare-Galesburg
      • Glenview, Illinois, Stany Zjednoczone, 60026
        • NorthShore University HealthSystem-Glenbrook Hospital
      • Highland Park, Illinois, Stany Zjednoczone, 60035
        • NorthShore University HealthSystem-Highland Park Hospital
      • Kewanee, Illinois, Stany Zjednoczone, 61443
        • Illinois CancerCare-Kewanee Clinic
      • Macomb, Illinois, Stany Zjednoczone, 61455
        • Illinois CancerCare-Macomb
      • Mattoon, Illinois, Stany Zjednoczone, 61938
        • Carle Physician Group-Mattoon/Charleston
      • Maywood, Illinois, Stany Zjednoczone, 60153
        • Loyola University Medical Center
      • Mount Vernon, Illinois, Stany Zjednoczone, 62864
        • SSM Health Good Samaritan
      • O'Fallon, Illinois, Stany Zjednoczone, 62269
        • Cancer Care Center of O'Fallon
      • Ottawa, Illinois, Stany Zjednoczone, 61350
        • Illinois CancerCare-Ottawa Clinic
      • Pekin, Illinois, Stany Zjednoczone, 61554
        • Illinois CancerCare-Pekin
      • Peoria, Illinois, Stany Zjednoczone, 61615
        • Illinois CancerCare-Peoria
      • Peru, Illinois, Stany Zjednoczone, 61354
        • Illinois CancerCare-Peru
      • Princeton, Illinois, Stany Zjednoczone, 61356
        • Illinois CancerCare-Princeton
      • Springfield, Illinois, Stany Zjednoczone, 62702
        • Southern Illinois University School of Medicine
      • Springfield, Illinois, Stany Zjednoczone, 62702
        • Springfield Clinic
      • Urbana, Illinois, Stany Zjednoczone, 61801
        • Carle Cancer Center
      • Washington, Illinois, Stany Zjednoczone, 61571
        • Illinois CancerCare - Washington
    • Indiana
      • Indianapolis, Indiana, Stany Zjednoczone, 46237
        • Franciscan Health Indianapolis
      • Indianapolis, Indiana, Stany Zjednoczone, 46202
        • Indiana University/Melvin and Bren Simon Cancer Center
      • Indianapolis, Indiana, Stany Zjednoczone, 46219
        • Community Cancer Center East
      • Indianapolis, Indiana, Stany Zjednoczone, 46227
        • Community Cancer Center South
      • Indianapolis, Indiana, Stany Zjednoczone, 46256
        • Community Cancer Center North
      • Kokomo, Indiana, Stany Zjednoczone, 46904
        • Community Howard Regional Health
      • Lafayette, Indiana, Stany Zjednoczone, 47905
        • Franciscan Saint Elizabeth Health - Lafayette East
      • Michigan City, Indiana, Stany Zjednoczone, 46360
        • Woodland Cancer Care Center
      • Mooresville, Indiana, Stany Zjednoczone, 46158
        • Franciscan Health Mooresville
      • Terre Haute, Indiana, Stany Zjednoczone, 47804
        • Union Hospital
    • Iowa
      • Ames, Iowa, Stany Zjednoczone, 50010
        • Mary Greeley Medical Center
      • Ames, Iowa, Stany Zjednoczone, 50010
        • McFarland Clinic - Ames
      • Bettendorf, Iowa, Stany Zjednoczone, 52722
        • University of Iowa Healthcare Cancer Services Quad Cities
      • Boone, Iowa, Stany Zjednoczone, 50036
        • McFarland Clinic - Boone
      • Cedar Rapids, Iowa, Stany Zjednoczone, 52403
        • Mercy Hospital
      • Cedar Rapids, Iowa, Stany Zjednoczone, 52403
        • Oncology Associates at Mercy Medical Center
      • Clive, Iowa, Stany Zjednoczone, 50325
        • Mercy Cancer Center-West Lakes
      • Clive, Iowa, Stany Zjednoczone, 50325
        • UI Health Care Mission Cancer and Blood - West Des Moines Clinic
      • Des Moines, Iowa, Stany Zjednoczone, 50314
        • Mercy Medical Center - Des Moines
      • Des Moines, Iowa, Stany Zjednoczone, 50314
        • Broadlawns Medical Center
      • Des Moines, Iowa, Stany Zjednoczone, 50309
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
      • Des Moines, Iowa, Stany Zjednoczone, 50314
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
      • Fort Dodge, Iowa, Stany Zjednoczone, 50501
        • McFarland Clinic - Trinity Cancer Center
      • Fort Dodge, Iowa, Stany Zjednoczone, 50501
        • UI Healthcare Mission Cancer and Blood - Fort Dodge
      • Iowa City, Iowa, Stany Zjednoczone, 52242
        • University of Iowa/Holden Comprehensive Cancer Center
      • Jefferson, Iowa, Stany Zjednoczone, 50129
        • McFarland Clinic - Jefferson
      • Marshalltown, Iowa, Stany Zjednoczone, 50158
        • McFarland Clinic - Marshalltown
      • West Des Moines, Iowa, Stany Zjednoczone, 50266
        • Mercy Medical Center-West Lakes
    • Kansas
      • Hays, Kansas, Stany Zjednoczone, 67601
        • HaysMed
      • Lawrence, Kansas, Stany Zjednoczone, 66044
        • Lawrence Memorial Hospital
      • Olathe, Kansas, Stany Zjednoczone, 66061
        • The University of Kansas Cancer Center - Olathe
      • Salina, Kansas, Stany Zjednoczone, 67401
        • Salina Regional Health Center
      • Topeka, Kansas, Stany Zjednoczone, 66606
        • University of Kansas Health System Saint Francis Campus
      • Westwood, Kansas, Stany Zjednoczone, 66205
        • University of Kansas Hospital-Westwood Cancer Center
      • Wichita, Kansas, Stany Zjednoczone, 67208
        • Cancer Center of Kansas-Wichita Medical Arts Tower
      • Wichita, Kansas, Stany Zjednoczone, 67214
        • Cancer Center of Kansas - Wichita
    • Kentucky
      • Bardstown, Kentucky, Stany Zjednoczone, 40004
        • CommonSpirit Saint Joseph Hospital - Bardstown
      • Lexington, Kentucky, Stany Zjednoczone, 40536
        • University of Kentucky/Markey Cancer Center
      • Lexington, Kentucky, Stany Zjednoczone, 40503
        • Baptist Health Lexington
      • Lexington, Kentucky, Stany Zjednoczone, 40509
        • CommonSpirit Saint Joseph Medical Center - East Lexington
      • Louisville, Kentucky, Stany Zjednoczone, 40202
        • Norton Hospital Pavilion and Medical Campus
      • Louisville, Kentucky, Stany Zjednoczone, 40241
        • Norton Brownsboro Hospital and Medical Campus
      • Louisville, Kentucky, Stany Zjednoczone, 40217
        • Norton Audubon Hospital and Medical Campus
    • Louisiana
      • Kenner, Louisiana, Stany Zjednoczone, 70065
        • Ochsner Medical Center Kenner
      • New Orleans, Louisiana, Stany Zjednoczone, 70121
        • Ochsner Medical Center Jefferson
    • Maine
      • Augusta, Maine, Stany Zjednoczone, 04330
        • Harold Alfond Center for Cancer Care
      • Bangor, Maine, Stany Zjednoczone, 04401
        • Eastern Maine Medical Center
      • Belfast, Maine, Stany Zjednoczone, 04915
        • MaineHealth Waldo Hospital
      • Biddeford, Maine, Stany Zjednoczone, 04005
        • MaineHealth Maine Medical Center - Biddeford
      • Brewer, Maine, Stany Zjednoczone, 04412
        • Lafayette Family Cancer Center-EMMC
      • Rockport, Maine, Stany Zjednoczone, 04856
        • Penobscot Bay Medical Center
      • Sanford, Maine, Stany Zjednoczone, 04073
        • MaineHealth Cancer Care and IV Therapy - Sanford
      • South Portland, Maine, Stany Zjednoczone, 04106
        • MaineHealth Cancer Care and IV Therapy - South Portland
    • Maryland
      • Baltimore, Maryland, Stany Zjednoczone, 21244
        • Kaiser Permanente-Woodlawn Medical Center
      • Easton, Maryland, Stany Zjednoczone, 21601
        • University of Maryland Shore Medical Center at Easton
      • Gaithersburg, Maryland, Stany Zjednoczone, 20879
        • Kaiser Permanente-Gaithersburg Medical Center
      • Largo, Maryland, Stany Zjednoczone, 20774
        • Kaiser Permanente - Largo Medical Center
      • Lutherville, Maryland, Stany Zjednoczone, 21093
        • Kaiser Permanente Lutherville - Timonium Medical Center
    • Massachusetts
      • Boston, Massachusetts, Stany Zjednoczone, 02215
        • Dana-Farber Cancer Institute
      • Lowell, Massachusetts, Stany Zjednoczone, 01854
        • Lowell General Hospital
    • Michigan
      • Ann Arbor, Michigan, Stany Zjednoczone, 48106
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
      • Bay City, Michigan, Stany Zjednoczone, 48706
        • McLaren Cancer Institute-Bay City
      • Bloomfield, Michigan, Stany Zjednoczone, 48302
        • McLaren Cancer Institute-Bloomfield
      • Brighton, Michigan, Stany Zjednoczone, 48114
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
      • Brighton, Michigan, Stany Zjednoczone, 48114
        • Trinity Health Medical Center - Brighton
      • Brownstown, Michigan, Stany Zjednoczone, 48183
        • Henry Ford Cancer Institute-Downriver
      • Canton, Michigan, Stany Zjednoczone, 48188
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
      • Canton, Michigan, Stany Zjednoczone, 48188
        • Trinity Health Medical Center - Canton
      • Chelsea, Michigan, Stany Zjednoczone, 48118
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
      • Chelsea, Michigan, Stany Zjednoczone, 48118
        • Chelsea Hospital
      • Clarkston, Michigan, Stany Zjednoczone, 48346
        • McLaren Cancer Institute-Clarkston
      • Clarkston, Michigan, Stany Zjednoczone, 48346
        • Hematology Oncology Consultants-Clarkston
      • Clarkston, Michigan, Stany Zjednoczone, 48346
        • Newland Medical Associates-Clarkston
      • Clinton Township, Michigan, Stany Zjednoczone, 48038
        • Henry Ford Macomb Hospital-Clinton Township
      • Dearborn, Michigan, Stany Zjednoczone, 48126
        • Henry Ford Medical Center-Fairlane
      • Detroit, Michigan, Stany Zjednoczone, 48202
        • Henry Ford Hospital
      • Detroit, Michigan, Stany Zjednoczone, 48201
        • Wayne State University/Karmanos Cancer Institute
      • Farmington Hills, Michigan, Stany Zjednoczone, 48334
        • Weisberg Cancer Treatment Center
      • Flint, Michigan, Stany Zjednoczone, 48532
        • McLaren Cancer Institute-Flint
      • Flint, Michigan, Stany Zjednoczone, 48532
        • Singh and Arora Hematology Oncology PC
      • Grand Rapids, Michigan, Stany Zjednoczone, 49503
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
      • Jackson, Michigan, Stany Zjednoczone, 49201
        • Allegiance Health
      • Kalamazoo, Michigan, Stany Zjednoczone, 49007
        • West Michigan Cancer Center
      • Lansing, Michigan, Stany Zjednoczone, 48910
        • Karmanos Cancer Institute at McLaren Greater Lansing
      • Lansing, Michigan, Stany Zjednoczone, 48912
        • University of Michigan Health - Sparrow Lansing
      • Lapeer, Michigan, Stany Zjednoczone, 48446
        • McLaren Cancer Institute-Lapeer Region
      • Livonia, Michigan, Stany Zjednoczone, 48154
        • Trinity Health Saint Mary Mercy Livonia Hospital
      • Livonia, Michigan, Stany Zjednoczone, 48154
        • Hope Cancer Clinic
      • Mount Clemens, Michigan, Stany Zjednoczone, 48043
        • McLaren Cancer Institute-Macomb
      • Mount Pleasant, Michigan, Stany Zjednoczone, 48858
        • McLaren Cancer Institute-Central Michigan
      • Novi, Michigan, Stany Zjednoczone, 48377
        • Henry Ford Medical Center-Columbus
      • Petoskey, Michigan, Stany Zjednoczone, 49770
        • McLaren Cancer Institute-Northern Michigan
      • Pontiac, Michigan, Stany Zjednoczone, 48341
        • Trinity Health Saint Joseph Mercy Oakland Hospital
      • Pontiac, Michigan, Stany Zjednoczone, 48341
        • Trinity Health IHA Medical Group-Alice Gustafson Center
      • Port Huron, Michigan, Stany Zjednoczone, 48060
        • McLaren-Port Huron
      • Saginaw, Michigan, Stany Zjednoczone, 48604
        • Oncology Hematology Associates of Saginaw Valley PC
      • Saginaw, Michigan, Stany Zjednoczone, 48601
        • MyMichigan Medical Center Saginaw
      • Tawas City, Michigan, Stany Zjednoczone, 48764
        • MyMichigan Medical Center Tawas
      • Traverse City, Michigan, Stany Zjednoczone, 49684
        • Munson Medical Center
      • West Bloomfield, Michigan, Stany Zjednoczone, 48322
        • Henry Ford West Bloomfield Hospital
      • West Branch, Michigan, Stany Zjednoczone, 48661
        • Saint Mary's Oncology/Hematology Associates of West Branch
      • Ypsilanti, Michigan, Stany Zjednoczone, 48197
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
    • Minnesota
      • Bemidji, Minnesota, Stany Zjednoczone, 56601
        • Sanford Joe Lueken Cancer Center
      • Burnsville, Minnesota, Stany Zjednoczone, 55337
        • Minnesota Oncology - Burnsville
      • Deer River, Minnesota, Stany Zjednoczone, 56636
        • Essentia Health - Deer River Clinic
      • Duluth, Minnesota, Stany Zjednoczone, 55805
        • Essentia Health Cancer Center
      • Hibbing, Minnesota, Stany Zjednoczone, 55746
        • Essentia Health Hibbing Clinic
      • Maplewood, Minnesota, Stany Zjednoczone, 55109
        • Saint John's Hospital - Healtheast
      • Maplewood, Minnesota, Stany Zjednoczone, 55109
        • Minnesota Oncology Hematology PA-Maplewood
      • Minneapolis, Minnesota, Stany Zjednoczone, 55415
        • Hennepin County Medical Center
      • Minneapolis, Minnesota, Stany Zjednoczone, 55454
        • Health Partners Inc
      • Saint Paul, Minnesota, Stany Zjednoczone, 55101
        • Regions Hospital
      • Saint Paul, Minnesota, Stany Zjednoczone, 55102
        • United Hospital
      • Sandstone, Minnesota, Stany Zjednoczone, 55072
        • Essentia Health Sandstone
      • Virginia, Minnesota, Stany Zjednoczone, 55792
        • Essentia Health Virginia Clinic
    • Mississippi
      • Grenada, Mississippi, Stany Zjednoczone, 38901
        • Baptist Cancer Center-Grenada
      • New Albany, Mississippi, Stany Zjednoczone, 38652
        • Baptist Memorial Hospital and Cancer Center-Union County
      • Oxford, Mississippi, Stany Zjednoczone, 38655
        • Baptist Memorial Hospital and Cancer Center-Oxford
      • Southhaven, Mississippi, Stany Zjednoczone, 38671
        • Baptist Memorial Hospital and Cancer Center-Desoto
    • Missouri
      • Ballwin, Missouri, Stany Zjednoczone, 63011
        • Mercy Oncology and Hematology - Clayton-Clarkson
      • Cape Girardeau, Missouri, Stany Zjednoczone, 63703
        • Saint Francis Medical Center
      • Columbia, Missouri, Stany Zjednoczone, 65212
        • MU Health - University Hospital/Ellis Fischel Cancer Center
      • Joplin, Missouri, Stany Zjednoczone, 64804
        • Freeman Health System
      • Joplin, Missouri, Stany Zjednoczone, 64804
        • Mercy Hospital Joplin
      • Kansas City, Missouri, Stany Zjednoczone, 64108
        • University Health Truman Medical Center
      • St Louis, Missouri, Stany Zjednoczone, 63109
        • Mercy Infusion Center - Chippewa
      • St Louis, Missouri, Stany Zjednoczone, 63141
        • Mercy Hospital Saint Louis
    • Montana
      • Anaconda, Montana, Stany Zjednoczone, 59711
        • Community Hospital of Anaconda
      • Billings, Montana, Stany Zjednoczone, 59101
        • Billings Clinic Cancer Center
      • Bozeman, Montana, Stany Zjednoczone, 59715
        • Bozeman Health Deaconess Hospital
      • Great Falls, Montana, Stany Zjednoczone, 59405
        • Great Falls Clinic
      • Great Falls, Montana, Stany Zjednoczone, 59405
        • Benefis Sletten Cancer Institute
      • Helena, Montana, Stany Zjednoczone, 59601
        • Saint Peter's Community Hospital
      • Kalispell, Montana, Stany Zjednoczone, 59901
        • Logan Health Medical Center
      • Missoula, Montana, Stany Zjednoczone, 59804
        • Community Medical Center
    • Nebraska
      • Omaha, Nebraska, Stany Zjednoczone, 68114
        • Nebraska Methodist Hospital
    • Nevada
      • Las Vegas, Nevada, Stany Zjednoczone, 89102
        • OptumCare Cancer Care at Charleston
      • Las Vegas, Nevada, Stany Zjednoczone, 89128
        • OptumCare Cancer Care at MountainView
      • Las Vegas, Nevada, Stany Zjednoczone, 89183
        • OptumCare Cancer Care at Fort Apache
      • Reno, Nevada, Stany Zjednoczone, 89502
        • Renown Regional Medical Center
    • New Hampshire
      • Lebanon, New Hampshire, Stany Zjednoczone, 03756
        • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
      • Manchester, New Hampshire, Stany Zjednoczone, 03104
        • Dartmouth Cancer Center - Manchester/ DCC Manchester
      • Nashua, New Hampshire, Stany Zjednoczone, 03063
        • Dartmouth Cancer Center - Nashua
    • New Jersey
      • Hamilton, New Jersey, Stany Zjednoczone, 08690
        • The Cancer Institute of New Jersey Hamilton
      • Morristown, New Jersey, Stany Zjednoczone, 07960
        • Morristown Medical Center
      • New Brunswick, New Jersey, Stany Zjednoczone, 08903
        • Rutgers Cancer Institute of New Jersey
      • Paramus, New Jersey, Stany Zjednoczone, 07652
        • The Valley Hospital - Luckow Pavilion
      • Ridgewood, New Jersey, Stany Zjednoczone, 07450
        • Valley Health System Ridgewood Campus
      • Somerville, New Jersey, Stany Zjednoczone, 08876
        • Robert Wood Johnson University Hospital Somerset
      • Summit, New Jersey, Stany Zjednoczone, 07902
        • Overlook Hospital
    • New Mexico
      • Albuquerque, New Mexico, Stany Zjednoczone, 87106
        • University of New Mexico Cancer Center
      • Albuquerque, New Mexico, Stany Zjednoczone, 87110
        • Presbyterian Kaseman Hospital
      • Las Cruces, New Mexico, Stany Zjednoczone, 88011
        • Memorial Medical Center-Las Cruces
      • Rio Rancho, New Mexico, Stany Zjednoczone, 87124
        • Presbyterian Rust Medical Center/Jorgensen Cancer Center
    • New York
      • Buffalo, New York, Stany Zjednoczone, 14263
        • Roswell Park Cancer Institute
      • Elmira, New York, Stany Zjednoczone, 14905
        • Arnot Ogden Medical Center/Falck Cancer Center
      • Lake Success, New York, Stany Zjednoczone, 11042
        • Northwell Health/Center for Advanced Medicine
      • New York, New York, Stany Zjednoczone, 10016
        • Laura and Isaac Perlmutter Cancer Center at NYU Langone
      • Rochester, New York, Stany Zjednoczone, 14642
        • University of Rochester
      • White Plains, New York, Stany Zjednoczone, 10601
        • Dickstein Cancer Treatment Center
    • North Carolina
      • Chapel Hill, North Carolina, Stany Zjednoczone, 27599
        • UNC Lineberger Comprehensive Cancer Center
      • Clinton, North Carolina, Stany Zjednoczone, 28328
        • Southeastern Medical Oncology Center-Clinton
      • Goldsboro, North Carolina, Stany Zjednoczone, 27534
        • Southeastern Medical Oncology Center-Goldsboro
      • Hendersonville, North Carolina, Stany Zjednoczone, 28791
        • Margaret R Pardee Memorial Hospital
      • Jacksonville, North Carolina, Stany Zjednoczone, 28546
        • Southeastern Medical Oncology Center-Jacksonville
      • Kenansville, North Carolina, Stany Zjednoczone, 28349
        • ECU Health Oncology Kenansville
      • Kinston, North Carolina, Stany Zjednoczone, 28501
        • ECU Health Oncology Kinston
      • Pinehurst, North Carolina, Stany Zjednoczone, 28374
        • FirstHealth of the Carolinas-Moore Regional Hospital
      • Richlands, North Carolina, Stany Zjednoczone, 28574
        • ECU Health Oncology Richlands
      • Winston-Salem, North Carolina, Stany Zjednoczone, 27157
        • Wake Forest University Health Sciences
    • North Dakota
      • Bismarck, North Dakota, Stany Zjednoczone, 58501
        • Sanford Bismarck Medical Center
      • Fargo, North Dakota, Stany Zjednoczone, 58122
        • Sanford Roger Maris Cancer Center
      • Fargo, North Dakota, Stany Zjednoczone, 58122
        • Sanford Broadway Medical Center
      • Grand Forks, North Dakota, Stany Zjednoczone, 58201
        • Altru Cancer Center
    • Ohio
      • Akron, Ohio, Stany Zjednoczone, 44307
        • Cleveland Clinic Akron General
      • Belpre, Ohio, Stany Zjednoczone, 45714
        • Strecker Cancer Center-Belpre
      • Centerville, Ohio, Stany Zjednoczone, 45459
        • Miami Valley Hospital South
      • Centerville, Ohio, Stany Zjednoczone, 45459
        • Dayton Physicians LLC-Miami Valley South
      • Chillicothe, Ohio, Stany Zjednoczone, 45601
        • Adena Regional Medical Center
      • Cincinnati, Ohio, Stany Zjednoczone, 45219
        • University of Cincinnati Cancer Center-UC Medical Center
      • Cleveland, Ohio, Stany Zjednoczone, 44111
        • Cleveland Clinic Cancer Center/Fairview Hospital
      • Columbus, Ohio, Stany Zjednoczone, 43214
        • Riverside Methodist Hospital
      • Columbus, Ohio, Stany Zjednoczone, 43210
        • Ohio State University Comprehensive Cancer Center
      • Columbus, Ohio, Stany Zjednoczone, 43219
        • The Mark H Zangmeister Center
      • Columbus, Ohio, Stany Zjednoczone, 43214
        • Columbus Oncology and Hematology Associates Inc
      • Columbus, Ohio, Stany Zjednoczone, 43228
        • Doctors Hospital
      • Columbus, Ohio, Stany Zjednoczone, 43213
        • Mount Carmel East Hospital
      • Columbus, Ohio, Stany Zjednoczone, 43215
        • Grant Medical Center
      • Columbus, Ohio, Stany Zjednoczone, 43222
        • Mount Carmel Health Center West
      • Dayton, Ohio, Stany Zjednoczone, 45409
        • Miami Valley Hospital
      • Delaware, Ohio, Stany Zjednoczone, 43015
        • Delaware Health Center-Grady Cancer Center
      • Delaware, Ohio, Stany Zjednoczone, 43015
        • Grady Memorial Hospital
      • Kettering, Ohio, Stany Zjednoczone, 45409
        • Greater Dayton Cancer Center
      • Lancaster, Ohio, Stany Zjednoczone, 43130
        • Fairfield Medical Center
      • Mansfield, Ohio, Stany Zjednoczone, 44906
        • Cleveland Clinic Cancer Center Mansfield
      • Mansfield, Ohio, Stany Zjednoczone, 44903
        • OhioHealth Mansfield Hospital
      • Marietta, Ohio, Stany Zjednoczone, 45750
        • Marietta Memorial Hospital
      • Marion, Ohio, Stany Zjednoczone, 43302
        • OhioHealth Marion General Hospital
      • Mayfield Heights, Ohio, Stany Zjednoczone, 44124
        • Hillcrest Hospital Cancer Center
      • Mount Vernon, Ohio, Stany Zjednoczone, 43050
        • Knox Community Hospital
      • Newark, Ohio, Stany Zjednoczone, 43055
        • Licking Memorial Hospital
      • Portsmouth, Ohio, Stany Zjednoczone, 45662
        • Southern Ohio Medical Center
      • Sandusky, Ohio, Stany Zjednoczone, 44870
        • North Coast Cancer Care
      • Sylvania, Ohio, Stany Zjednoczone, 43560
        • ProMedica Flower Hospital
      • Warrensville Heights, Ohio, Stany Zjednoczone, 44122
        • South Pointe Hospital
      • West Chester, Ohio, Stany Zjednoczone, 45069
        • University of Cincinnati Cancer Center-West Chester
      • Westerville, Ohio, Stany Zjednoczone, 43081
        • Saint Ann's Hospital
      • Zanesville, Ohio, Stany Zjednoczone, 43701
        • Genesis Healthcare System Cancer Care Center
    • Oklahoma
      • Lawton, Oklahoma, Stany Zjednoczone, 73505
        • Cancer Centers of Southwest Oklahoma Research
      • Oklahoma City, Oklahoma, Stany Zjednoczone, 73104
        • University of Oklahoma Health Sciences Center
      • Tulsa, Oklahoma, Stany Zjednoczone, 74146
        • Oklahoma Cancer Specialists and Research Institute-Tulsa
      • Tulsa, Oklahoma, Stany Zjednoczone, 74133
        • Cancer Treatment Centers of America
    • Oregon
      • Bend, Oregon, Stany Zjednoczone, 97701
        • Saint Charles Health System
      • Clackamas, Oregon, Stany Zjednoczone, 97015
        • Clackamas Radiation Oncology Center
      • Clackamas, Oregon, Stany Zjednoczone, 97015
        • Providence Cancer Institute Clackamas Clinic
      • Newberg, Oregon, Stany Zjednoczone, 97132
        • Providence Newberg Medical Center
      • Ontario, Oregon, Stany Zjednoczone, 97914
        • Saint Alphonsus Cancer Care Center-Ontario
      • Oregon City, Oregon, Stany Zjednoczone, 97045
        • Providence Willamette Falls Medical Center
      • Portland, Oregon, Stany Zjednoczone, 97213
        • Providence Portland Medical Center
      • Portland, Oregon, Stany Zjednoczone, 97225
        • Providence Saint Vincent Medical Center
    • Pennsylvania
      • Allentown, Pennsylvania, Stany Zjednoczone, 18103
        • Lehigh Valley Hospital-Cedar Crest
      • Allentown, Pennsylvania, Stany Zjednoczone, 18104
        • Saint Luke's Cancer Center - Allentown
      • Bethlehem, Pennsylvania, Stany Zjednoczone, 18017
        • Lehigh Valley Hospital - Muhlenberg
      • Bethlehem, Pennsylvania, Stany Zjednoczone, 18015
        • Saint Luke's University Hospital-Bethlehem Campus
      • Easton, Pennsylvania, Stany Zjednoczone, 18045
        • Saint Luke's Hospital-Anderson Campus
      • Erie, Pennsylvania, Stany Zjednoczone, 16544
        • Saint Vincent Hospital
      • Harrisburg, Pennsylvania, Stany Zjednoczone, 17109
        • UPMC Pinnacle Cancer Center/Community Osteopathic Campus
      • Jefferson Hills, Pennsylvania, Stany Zjednoczone, 15025
        • Jefferson Hospital
      • Monroeville, Pennsylvania, Stany Zjednoczone, 15146
        • Forbes Hospital
      • Natrona Heights, Pennsylvania, Stany Zjednoczone, 15065
        • Allegheny Valley Hospital
      • Pittsburgh, Pennsylvania, Stany Zjednoczone, 15212
        • Allegheny General Hospital
      • Pittsburgh, Pennsylvania, Stany Zjednoczone, 15224
        • West Penn Hospital
      • Pittsburgh, Pennsylvania, Stany Zjednoczone, 15232
        • UPMC Hillman Cancer Center
      • Quakertown, Pennsylvania, Stany Zjednoczone, 18951
        • Saint Luke's Hospital-Quakertown Campus
      • West Reading, Pennsylvania, Stany Zjednoczone, 19611
        • Reading Hospital
      • Wexford, Pennsylvania, Stany Zjednoczone, 15090
        • Wexford Health and Wellness Pavilion
      • Willow Grove, Pennsylvania, Stany Zjednoczone, 19090
        • Asplundh Cancer Pavilion
    • South Carolina
      • Anderson, South Carolina, Stany Zjednoczone, 29621
        • AnMed Health Cancer Center
      • Beaufort, South Carolina, Stany Zjednoczone, 29902
        • Beaufort Memorial Hospital
      • Boiling Springs, South Carolina, Stany Zjednoczone, 29316
        • Prisma Health Cancer Institute - Spartanburg
      • Easley, South Carolina, Stany Zjednoczone, 29640
        • Prisma Health Cancer Institute - Easley
      • Greenville, South Carolina, Stany Zjednoczone, 29605
        • Prisma Health Cancer Institute - Faris
      • Greenville, South Carolina, Stany Zjednoczone, 29607
        • Saint Francis Cancer Center
      • Greenville, South Carolina, Stany Zjednoczone, 29615
        • Prisma Health Cancer Institute - Eastside
      • Greenville, South Carolina, Stany Zjednoczone, 29605
        • Prisma Health Cancer Institute - Butternut
      • Greenville, South Carolina, Stany Zjednoczone, 29601
        • Saint Francis Hospital
      • Greer, South Carolina, Stany Zjednoczone, 29650
        • Prisma Health Cancer Institute - Greer
      • Seneca, South Carolina, Stany Zjednoczone, 29672
        • Prisma Health Cancer Institute - Seneca
      • Spartanburg, South Carolina, Stany Zjednoczone, 29303
        • Spartanburg Medical Center
    • South Dakota
      • Aberdeen, South Dakota, Stany Zjednoczone, 57401
        • Avera Cancer Institute-Aberdeen
      • Sioux Falls, South Dakota, Stany Zjednoczone, 57105
        • Avera Cancer Institute
      • Sioux Falls, South Dakota, Stany Zjednoczone, 57117-5134
        • Sanford USD Medical Center - Sioux Falls
      • Sioux Falls, South Dakota, Stany Zjednoczone, 57104
        • Sanford Cancer Center Oncology Clinic
    • Tennessee
      • Bristol, Tennessee, Stany Zjednoczone, 37620
        • Bristol Regional Medical Center
      • Collierville, Tennessee, Stany Zjednoczone, 38017
        • Baptist Memorial Hospital and Cancer Center-Collierville
      • Cookeville, Tennessee, Stany Zjednoczone, 38501
        • Cookeville Regional Medical Center
      • Johnson City, Tennessee, Stany Zjednoczone, 37604
        • Wellmont Medical Associates Oncology and Hematology-Johnson City
      • Kingsport, Tennessee, Stany Zjednoczone, 37660
        • Ballad Health Cancer Care - Kingsport
      • Kingsport, Tennessee, Stany Zjednoczone, 37660
        • Wellmont Holston Valley Hospital and Medical Center
      • Memphis, Tennessee, Stany Zjednoczone, 38120
        • Baptist Memorial Hospital and Cancer Center-Memphis
    • Texas
      • Amarillo, Texas, Stany Zjednoczone, 79106
        • The Don and Sybil Harrington Cancer Center
      • Beaumont, Texas, Stany Zjednoczone, 77701
        • Baptist Hospitals of Southeast Texas Cancer Center
      • Conroe, Texas, Stany Zjednoczone, 77384
        • UT MD Anderson - The Woodlands
      • Dallas, Texas, Stany Zjednoczone, 75235
        • Parkland Memorial Hospital
      • Dallas, Texas, Stany Zjednoczone, 75390
        • UT Southwestern/Simmons Cancer Center-Dallas
      • Edinburg, Texas, Stany Zjednoczone, 78539
        • STCC at DHR Health Institute for Research and Development
      • Houston, Texas, Stany Zjednoczone, 77026-1967
        • Lyndon Baines Johnson General Hospital
      • Houston, Texas, Stany Zjednoczone, 77030
        • UT MD Anderson Cancer Center
      • Houston, Texas, Stany Zjednoczone, 77030
        • Houston Methodist Hospital
      • Houston, Texas, Stany Zjednoczone, 77079
        • UT MD Anderson - West Houston
      • League City, Texas, Stany Zjednoczone, 77573
        • UT MD Anderson - League City
      • Port Arthur, Texas, Stany Zjednoczone, 77642
        • Baptist Regional Cancer Network-Cancer Center of Southeast Texas
      • Sugar Land, Texas, Stany Zjednoczone, 77478
        • UT MD Anderson - Sugar Land
      • Temple, Texas, Stany Zjednoczone, 76508
        • Scott and White Memorial Hospital
    • Utah
      • Salt Lake City, Utah, Stany Zjednoczone, 84112
        • Huntsman Cancer Institute/University of Utah
    • Vermont
      • Saint Johnsbury, Vermont, Stany Zjednoczone, 05819
        • Dartmouth Cancer Center - North
    • Virginia
      • Bristol, Virginia, Stany Zjednoczone, 24201
        • Ballad Health Cancer Care - Bristol
      • Burke, Virginia, Stany Zjednoczone, 22015
        • Kaiser Permanente-Burke Medical Center
      • Fishersville, Virginia, Stany Zjednoczone, 22939
        • Augusta Health Center for Cancer and Blood Disorders
      • Lynchburg, Virginia, Stany Zjednoczone, 24501
        • Centra Alan B Pearson Regional Cancer Center
      • McLean, Virginia, Stany Zjednoczone, 22102
        • Kaiser Permanente Tysons Corner Medical Center
      • Norton, Virginia, Stany Zjednoczone, 24273
        • Ballad Health Cancer Care - Norton
      • Richmond, Virginia, Stany Zjednoczone, 23235
        • VCU Massey Cancer Center at Stony Point
      • Richmond, Virginia, Stany Zjednoczone, 23229
        • Virginia Cancer Institute
      • Richmond, Virginia, Stany Zjednoczone, 23298
        • VCU Massey Comprehensive Cancer Center
      • South Hill, Virginia, Stany Zjednoczone, 23970
        • VCU Community Memorial Health Center
      • Woodbridge, Virginia, Stany Zjednoczone, 22192
        • Kaiser Permanente-Caton Hill Medical Center
    • Washington
      • Edmonds, Washington, Stany Zjednoczone, 98026
        • Swedish Cancer Institute-Edmonds
      • Issaquah, Washington, Stany Zjednoczone, 98029
        • Swedish Cancer Institute-Issaquah
      • Port Townsend, Washington, Stany Zjednoczone, 98368
        • Jefferson Healthcare
      • Seattle, Washington, Stany Zjednoczone, 98122
        • Swedish Medical Center-First Hill
      • Spokane, Washington, Stany Zjednoczone, 99204
        • MultiCare Deaconess Cancer and Blood Specialty Center - Downtown
      • Spokane, Washington, Stany Zjednoczone, 99218
        • MultiCare Deaconess Cancer and Blood Specialty Center - North
    • West Virginia
      • Charleston, West Virginia, Stany Zjednoczone, 25304
        • Vandalia Health/CAMC Institute for Academic Medicine
      • Morgantown, West Virginia, Stany Zjednoczone, 26506
        • West Virginia University Healthcare
      • Parkersburg, West Virginia, Stany Zjednoczone, 26101
        • Camden Clark Medical Center
    • Wisconsin
      • Antigo, Wisconsin, Stany Zjednoczone, 54409
        • Aspirus Cancer Care-Antigo-Volm Cancer Center
      • Appleton, Wisconsin, Stany Zjednoczone, 54911
        • ThedaCare Regional Cancer Center
      • Appleton, Wisconsin, Stany Zjednoczone, 54915
        • Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton
      • Ashland, Wisconsin, Stany Zjednoczone, 54806
        • Duluth Clinic Ashland
      • Brookfield, Wisconsin, Stany Zjednoczone, 53045
        • Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield
      • Eau Claire, Wisconsin, Stany Zjednoczone, 54701
        • Marshfield Medical Center-EC Cancer Center
      • Franklin, Wisconsin, Stany Zjednoczone, 53132
        • Reiman Cancer Center-Ascension Wisconsin Health Center-Rawson
      • Green Bay, Wisconsin, Stany Zjednoczone, 54301
        • Bellin Memorial Hospital
      • Janesville, Wisconsin, Stany Zjednoczone, 53548
        • Mercyhealth Hospital and Cancer Center - Janesville
      • Johnson Creek, Wisconsin, Stany Zjednoczone, 53038
        • University of Wisconsin Carbone Cancer Center - Johnson Creek
      • La Crosse, Wisconsin, Stany Zjednoczone, 54601
        • Gundersen Lutheran Medical Center
      • Madison, Wisconsin, Stany Zjednoczone, 53792
        • University of Wisconsin Carbone Cancer Center - University Hospital
      • Madison, Wisconsin, Stany Zjednoczone, 53718
        • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
      • Marshfield, Wisconsin, Stany Zjednoczone, 54449
        • Marshfield Medical Center-Marshfield
      • Medford, Wisconsin, Stany Zjednoczone, 54451
        • Aspirus Medford Hospital
      • Minocqua, Wisconsin, Stany Zjednoczone, 54548
        • Marshfield Medical Center - Minocqua
      • Mukwonago, Wisconsin, Stany Zjednoczone, 53149
        • ProHealth D N Greenwald Center
      • New Richmond, Wisconsin, Stany Zjednoczone, 54017
        • Cancer Center of Western Wisconsin
      • Oconomowoc, Wisconsin, Stany Zjednoczone, 53066
        • ProHealth Oconomowoc Memorial Hospital
      • Oshkosh, Wisconsin, Stany Zjednoczone, 54904
        • Ascension Northeast Wisconsin-Mercy Hospital-Oshkosh
      • Racine, Wisconsin, Stany Zjednoczone, 53405
        • Ascension All Saints Hospital-Spring Street-Racine
      • Rhinelander, Wisconsin, Stany Zjednoczone, 54501
        • Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
      • Rice Lake, Wisconsin, Stany Zjednoczone, 54868
        • Marshfield Medical Center-Rice Lake
      • Stevens Point, Wisconsin, Stany Zjednoczone, 54482
        • Marshfield Medical Center-River Region at Stevens Point
      • Waukesha, Wisconsin, Stany Zjednoczone, 53188
        • UW Cancer Center at ProHealth Care
      • Waukesha, Wisconsin, Stany Zjednoczone, 53188
        • ProHealth Waukesha Memorial Hospital
      • Wausau, Wisconsin, Stany Zjednoczone, 54401
        • Aspirus Cancer Care-Wausau
      • Wauwatosa, Wisconsin, Stany Zjednoczone, 53226
        • Ascension Southeast Wisconsin Hospital-Mayfair Road-Wauwatosa
      • Weston, Wisconsin, Stany Zjednoczone, 54476
        • Marshfield Medical Center - Weston
      • Wisconsin Rapids, Wisconsin, Stany Zjednoczone, 54494
        • Aspirus Cancer Care - Wisconsin Rapids
    • Wyoming
      • Cheyenne, Wyoming, Stany Zjednoczone, 82001
        • Cheyenne Regional Medical Center-West
      • Cody, Wyoming, Stany Zjednoczone, 82414
        • Billings Clinic-Cody

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

18 lat i starsze (Dorosły, Starszy dorosły)

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion Criteria:

  • The patient must have signed and dated an Institutional Review Board (IRB)-approved consent form that conforms to federal and institutional guidelines

  • Age >= 18 years

  • Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2

  • Diagnosis of metastatic adenocarcinoma of colon or rectum without previous chemotherapy or any other systemic therapy for metastatic colorectal cancer except for one cycle of FOLFOX or capecitabine and oxaliplatin (CAPOX), either with or without bevacizumab prior to enrollment. Upon enrollment, the preceding single cycle of FOLFOX or FOLFOX + bevacizumab, if the patient received one, will not count towards patients' assessments per protocol. Cycle 1 day 1 (C1D1) of atezolizumab or C1D1 of mFOLFOX6/bevacizumab + atezolizumab will correspond to the first day the patient received therapy on trial

  • Tumor determined to be mismatch-repair deficient (dMMR) by Clinical Laboratory Improvement Act (CLIA)-certified immunohistochemical (IHC) assay with a panel of all four IHC markers, including MLH1, MSH2, PMS2, and MSH6; alternatively, MSI-H diagnosed by polymerase chain reaction (PCR)-based assessment of microsatellite alterations (either Bethesda markers or Pentaplex panel) or by next-generation sequencing (NGS) are eligible

  • Documentation by PET/CT scan, CT scan, or MRI that the patient has measurable metastatic disease per RECIST 1.1

  • No immediate need for surgical intervention for the primary tumor or palliative diversion/bypass

  • Absolute neutrophil count (ANC) must be >= 1500/mm^3 (obtained within 28 days prior randomization)

  • Platelet count must be >= 100,000/mm^3 (obtained within 28 days prior randomization)

  • Hemoglobin must be >= 8 g/dL (obtained within 28 days prior randomization)

  • Total bilirubin must be =< 4 x ULN (upper limit of normal) (obtained within 28 days prior randomization); and

  • Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) must be =< 3 x ULN for the lab with the following exception: for patients with documented liver metastases, AST and ALT must be =< 5 x ULN (obtained within 28 days prior randomization)

  • Calculated creatinine clearance >= 30 mL/min (obtained within 28 days prior randomization)

  • A urine sample tested for proteinuria by either the dipstick method, urinalysis (UA), or a urine protein creatinine (UPC) ratio:

    • The dipstick method must indicate 0-1+ protein; if dipstick reading is >= 2+, a 24-hour urine must be done and it must demonstrate < 1.0 g of protein per 24 hours or a UPC ratio < 1.0
    • A urine protein creatinine (UPC) ratio must be < 1.0; if the UPC ratio is >= 1.0 a 24-hour urine must be done and it must demonstrate < 1.0 g of protein per 24 hours
    • Urinalysis must indicate < 30 mg/dl. If urinalysis >= 30 mg/dl, a 24-hour urine must be done and it must demonstrate < 1.0 g of protein per 24 hours or a UPC ratio < 1.0
  • International normalized ratio of prothrombin time (INR) and prothrombin time (PT) must be =< 1.5 x ULN for the lab within 28 days before randomization; patients who are therapeutically treated with an agent such as warfarin may participate if they are on a stable dose and no underlying abnormality in coagulation parameters exists per medical history, regardless of PT/INR results

  • Pregnancy test done within 28 days prior randomization must be negative (for women of childbearing potential only); pregnancy testing should be performed according to institutional standards; administration of atezolizumab or mFOLFOX6/bevacizumab/atezolizumab may have an adverse effect on pregnancy and poses a risk to the human fetus, including embryo-lethality; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately

  • Women of child-bearing potential and men must agree to use adequate contraception methods that result in a failure rate of < 1% per year during the treatment period (hormonal or barrier method of birth control; abstinence) prior to study entry, for the duration of study participation, and for 5 months (150 days) after the last dose of atezolizumab, 6 months after the last dose of bevacizumab, and 6 months after the last dose of mFOLFOX6; a woman is considered to be of childbearing potential if she is not postmenopausal, has not reached a postmenopausal state (>= 12 continuous months of amenorrhea with no identified cause other than menopause), and has not undergone surgical sterilization (removal of ovaries and/or uterus); examples of contraceptive methods with a failure rate of < 1% per year include: bilateral tubal ligation; male partner sterilization; intrauterine devices; the reliability of sexual abstinence should be evaluated in relation to the duration of the clinical study and the preferred and usual lifestyle of the patient; periodic abstinence (e.g., calendar, ovulation, symptothermal, or postovulation methods) and withdrawal are not acceptable methods of contraception; men must refrain from donating sperm during this same period

Exclusion Criteria:

  • Known hypersensitivity to Chinese hamster ovary cell products or other recombinant human antibodies, fluoropyrimidines, folic acid derivatives or oxaliplatin

  • Uncontrolled high blood pressure defined as systolic blood pressure (BP) > 150 mmHg or diastolic BP > 100 mmHg with or without anti-hypertensive medication; patients with initial BP elevations are eligible if initiation or adjustment of BP medication lowers pressure to meet entry criteria

  • Documented New York Heart Association (NYHA) class III or IV congestive heart failure

  • Serious or non-healing wound, skin ulcer, or bone fracture

  • History of inherited bleeding diathesis, gastrointestinal (GI) perforation, significant vascular disease (e.g., aortic aneurysm requiring surgical repair or recent arterial thrombosis or symptomatic peripheral ischemia, transient ischemic attack [TIA], cerebrovascular accident [CVA] or arterial thrombotic event), abdominal fistula, intra-abdominal abscess, or active GI bleeding (with cause not addressed) within 6 months prior to randomization, or other medical condition in the opinion of the treating oncologist that makes the risk of cardiovascular or bleeding complications with bevacizumab use unacceptably high

  • Other malignancies are excluded unless the patient has completed therapy for the malignancy >= 12 months prior to randomization and is considered disease-free; patients with the following cancers are eligible if diagnosed and treated within the past 12 months: in situ carcinomas or basal cell and squamous cell carcinoma of the skin

  • Known DPD (dihydro pyrimidine dehydrogenase) deficiency

  • Symptomatic peripheral sensory neuropathy >= grade 2 (Common Terminology Criteria for Adverse Events [CTCAE] version [v] 5.0)

  • Prior treatment with oxaliplatin chemotherapy within 6 months prior to randomization

  • History of grade 2 hemoptysis (defined as 2.5 mL of bright red blood per episode) within 1 month prior to screening

  • Prior treatment with anti-PD-1, or anti-PD-L1 therapeutic antibody or pathway-targeting agents; patients who have received prior treatment with anti-CTLA-4 may be enrolled provided the following requirements are met:

    • Minimum of 12 weeks from the first dose of anti-CTLA-4 and > 6 weeks from the last dose to randomization
    • No history of severe immune-related adverse effects (CTCAE grade 3 and 4) from anti-CTLA-4
  • Treatment with systemic immunosuppressive medications (including, but not limited to, prednisone, cyclophosphamide, azathioprine, methotrexate, thalidomide, and anti-tumor necrosis factor [anti-TNF] agents) within 14 days prior to randomization; however,

    • Patients who have received acute, low dose, systemic immunosuppressant medications (e.g., a one-time dose of dexamethasone for nausea; or chronic daily treatment with corticosteroids with a dose of =< 10 mg/day methylprednisolone equivalent) may be enrolled
    • The use of inhaled corticosteroids and mineralocorticoids (e.g., fludrocortisone) for patients with orthostatic hypotension or adrenocortical insufficiency is allowed
  • Known clinically significant liver disease, including active viral, alcoholic, or other hepatitis; cirrhosis; fatty liver; and inherited liver disease; however,

    • Patients with past or resolved hepatitis B infection (defined as having a negative hepatitis B surface antigen [HbsAg] test and a positive anti-HBc [antibody to hepatitis B core antigen] antibody test) are eligible if polymerase chain reaction (PCR) for hepatits B virus (HBV) ribonucleic acid (RNA) is negative per local guidelines
    • Patients positive for hepatitis C virus (HCV) antibody are eligible only if polymerase chain reaction (PCR) is negative for HCV RNA per local guidelines
  • History or risk of autoimmune disease, including, but not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular thrombosis associated with antiphospholipid syndrome, Wegener's granulomatosis, Sjogren's syndrome, Bell's palsy, Guillain-Barre syndrome, multiple sclerosis, autoimmune thyroid disease, vasculitis, or glomerulonephritis; however,

    • Patients with a history of autoimmune hypothyroidism on a stable dose of thyroid replacement hormone may be eligible

    • Patients with controlled type 1 diabetes mellitus on a stable insulin regimen may be eligible

    • Patients with eczema, psoriasis, lichen simplex chronicus or vitiligo with dermatologic manifestations only (e.g., patients with psoriatic arthritis would be excluded) are permitted provided that they meet the following conditions:

      • Patients with psoriasis must have a baseline ophthalmologic exam to rule out ocular manifestations
      • Rash must cover less than 10% of body surface area (BSA)
      • Disease is well controlled at baseline and only requiring low potency topical steroids (e.g., hydrocortisone 2.5%, hydrocortisone butyrate 0.1%, fluocinolone 0.01%, desonide 0.05%, alclometasone dipropionate 0.05%)
      • No acute exacerbations of underlying condition within the last 12 months (not requiring psoralen plus ultraviolet A radiation [PUVA], methotrexate, retinoids, biologic agents, oral calcineurin inhibitors; high potency or oral steroids)
  • History of idiopathic pulmonary fibrosis, organizing pneumonia (i.e., bronchiolitis obliterans, cryptogenic organizing pneumonia, etc.), or active or recently active (within 90 days of randomization) pneumonitis (including drug induced) that required systemic immunosuppressive therapy (i.e. corticosteroids, etc.). History of radiation pneumonitis in the radiation field (fibrosis) is permitted

  • History of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric or humanized antibodies or fusion proteins

  • Patients with known active tuberculosis (TB) are excluded

  • Severe infections within 28 days prior to randomization, including but not limited to, hospitalization for complications of infection, bacteremia, or severe pneumonia

  • Signs or symptoms of infection within 14 days prior to randomization

  • Received oral or intravenous (IV) antibiotics within 14 days prior to randomization; patients receiving prophylactic antibiotics (e.g., for prevention of a urinary tract infection or chronic obstructive pulmonary disease) are eligible

  • Major surgical procedure, open biopsy, or significant traumatic injury within 28 days prior to randomization or anticipation of need for a major surgical procedure during the course of the study

  • The administration of a live, attenuated vaccine within 28 days prior to randomization

  • Pregnant women are excluded from this study because atezolizumab is an agent with the potential for teratogenic or abortifacient effects; because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with atezolizumab, breastfeeding should be discontinued if the mother is treated with atezolizumab; these potential risks may also apply to other agents used in this study; (Note: pregnancy testing should be performed within 28 days prior to randomization according to institutional standards for women of childbearing potential)

  • Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial

  • Patients with prior allogeneic bone marrow transplantation or prior solid organ transplantation

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Brak (otwarta etykieta)

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Aktywny komparator: Arm I (bevacizumab, mFOLFOX6)

Patients receive bevacizumab intravenously (IV) over 30-90 minutes on day 1, oxaliplatin IV over 2 hours on day 1 of cycles 1-10, leucovorin calcium IV over 2 hours on day 1, and fluorouracil IV over 46-48 hours on days 1 and 2. Treatment with oxaliplatin repeats every 2 weeks for up to 10 cycles in the absence of disease progression or unacceptable toxicity. Treatment of bevacizumab, leucovorin calcium, and fluorouracil repeat every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial. (CLOSED TO ACCRUAL)

Ancillary studies

Inne nazwy:
  • Ocena jakości życia

Given IV

Inne nazwy:
  • Avastin
  • ABP 215
  • Anty-VEGF
  • Humanizowane przeciwciało monoklonalne anty-VEGF
  • Przeciwciało monoklonalne anty-VEGF SIBP04
  • Anty-VEGF rhuMAb
  • Bewacyzumab awwb
  • Bewacyzumab Biopodobny ABP 215
  • Bewacyzumab Biopodobny BEVZ92
  • Bevacizumab Biopodobny BI 695502
  • Bewacizumab Biopodobny CBT 124
  • Bewacyzumab Biopodobny CT-P16
  • Bewacyzumab Biopodobny FKB238
  • Bevacizumab Biopodobny GB-222
  • Bevacizumab Biopodobny HD204
  • Bevacizumab Biopodobny HLX04
  • Bewacyzumab Biopodobny IBI305
  • Bewacyzumab biopodobny LY01008
  • Bevacizumab Biopodobny MIL60
  • Bevacizumab Biopodobny Mvasi
  • Bevacizumab Biopodobny MYL-1402O
  • Bevacizumab Biopodobny QL 1101
  • Bewacyzumab Biopodobny RPH-001
  • Bewacizumab Biopodobny SCT501
  • Bevacizumab Biopodobny Zirabew
  • Bevacizumab-awwb
  • Bevacizumab-bvzr
  • BP102
  • BP102 Biopodobny
  • HD204
  • Immunoglobulina G1 (ludzko-mysi monoklonalny rhuMab-VEGF łańcuch gamma przeciwludzki czynnik wzrostu śródbłonka naczyniowego), dwusiarczek z ludzko-mysim monoklonalnym łańcuchem lekkim rhuMab-VEGF, dimer
  • Mvasi
  • MYL-1402O
  • Rekombinowane humanizowane przeciwciało monoklonalne anty-VEGF
  • rhuMab-VEGF
  • SCT501
  • SIP 04
  • SIBP-04
  • SIBP04
  • Zirabew
  • Avegra
  • QL1101
  • IBI305
  • Byvasda
  • Bewacyzumab Biopodobny QL1101
  • BAT1706
  • BAT 1706
  • BAT-1706
  • BAT1706 Biopodobny
  • Bewacizumab Biopodobny BAT1706
  • Bewacyzumab-adcd
  • CT-P16
  • Vegzelma
  • Alymsys
  • ABP-215
  • ABP215
  • Aybintio
  • Bewacyzumab-aybi
  • Odpowiednik bewacyzumabu
  • Bewacyzumab-maly
  • Bewacyzumab-onbe
  • CT P16
  • CTP16
  • Równy
  • Onbevzi
  • Avzivi
  • Bewacyzumab Biopodobny MB02
  • Bewacyzumab-tnjn
  • FKB 238
  • FKB-238
  • FKB238
  • MB 02
  • MB-02
  • MB02
  • Oyavas
  • PF 06439535
  • PF-06439535
  • PF06439535
  • Bevacizumab-aveg
  • Bevacizumab-byva
  • Bevacizumab-nwgd
  • Jobevne
  • IBI 305
  • IBI-305

Given IV

Inne nazwy:
  • 5-fluracyl
  • Fluracyl
  • 5 Fluorouracyl
  • 5 Fluorouracylum
  • 5 fu
  • 5-Fluoro-2,4(1H, 3H)-pirymidynodion
  • 5-fluorouracyl
  • 5-Fu
  • 5FU
  • AccuSite
  • Carac
  • Fluorouracyl
  • Fluouracyl
  • Flurablastyna
  • Fluracedyl
  • Fluril
  • Fluroblastyna
  • Rybofluor
  • Rz 2-9757
  • Ro-2-9757

Undergo MRI

Inne nazwy:
  • MRI
  • Rezonans magnetyczny
  • Skanowanie rezonansu magnetycznego
  • Obrazowanie medyczne, rezonans magnetyczny / jądrowy rezonans magnetyczny
  • PAN
  • Obrazowanie MR
  • Obrazowanie NMR
  • NMRI
  • Obrazowanie magnetycznego rezonansu jądrowego
  • Obrazowanie metodą rezonansu magnetycznego (MRI)
  • sMRI
  • Rezonans magnetyczny (zabieg)
  • Strukturalny MRI

Ancillary studies

Undergo collection of blood samples

Inne nazwy:
  • Pobieranie próbek biologicznych
  • Zebrano próbki biologiczne
  • Kolekcja próbek

Given IV

Inne nazwy:
  • 1-OHP
  • Dakotyna
  • Dacplat
  • Eloksatyna
  • Ai Heng
  • Aiheng
  • Diaminocykloheksan Oxalatoplatinum
  • JM-83
  • Oksalatoplatyna
  • Szczawianoplatyna
  • 54780 RP
  • RP-54780
  • SR-96669
  • SR96669
  • Elplat
  • JM 83
  • JM83
  • RP54780
  • SR 96669

Undergo CT or CT/PET

Inne nazwy:
  • Tomografia komputerowa
  • KOT
  • Skanowanie CAT
  • Tomografia komputerowa osiowa
  • Komputerowa tomografia osiowa
  • tomografia
  • Komputerowa tomografia osiowa (zabieg)
  • Tomografia komputerowa (CT).
  • Diagnostyczny skan CAT
  • Diagnostyczny typ usługi skanowania CAT

Given IV

Inne nazwy:
  • Kwas foliowy

Undergo CT/PET

Inne nazwy:
  • Obrazowanie medyczne, pozytonowa tomografia emisyjna
  • ZWIERZAK DOMOWY
  • Skanowanie zwierzęcia
  • Skan pozytonowej tomografii emisyjnej
  • Pozytonowa emisyjna tomografia komputerowa
  • PT
  • Pozytronowa tomografia emisyjna (zabieg)
Eksperymentalny: Arm II (atezolizumab)

Patients receive atezolizumab IV over 30-60 minutes on day 1. Treatment repeats every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial.

Ancillary studies

Inne nazwy:
  • Ocena jakości życia

Undergo MRI

Inne nazwy:
  • MRI
  • Rezonans magnetyczny
  • Skanowanie rezonansu magnetycznego
  • Obrazowanie medyczne, rezonans magnetyczny / jądrowy rezonans magnetyczny
  • PAN
  • Obrazowanie MR
  • Obrazowanie NMR
  • NMRI
  • Obrazowanie magnetycznego rezonansu jądrowego
  • Obrazowanie metodą rezonansu magnetycznego (MRI)
  • sMRI
  • Rezonans magnetyczny (zabieg)
  • Strukturalny MRI

Ancillary studies

Undergo collection of blood samples

Inne nazwy:
  • Pobieranie próbek biologicznych
  • Zebrano próbki biologiczne
  • Kolekcja próbek

Given IV

Inne nazwy:
  • Tecentrik
  • MPDL3280A
  • RO5541267
  • RG7446
  • MPDL 3280A
  • MPDL 328OA
  • MPDL-3280A
  • MPDL328OA
  • RG-7446
  • RO 5541267
  • RO-5541267

Undergo CT or CT/PET

Inne nazwy:
  • Tomografia komputerowa
  • KOT
  • Skanowanie CAT
  • Tomografia komputerowa osiowa
  • Komputerowa tomografia osiowa
  • tomografia
  • Komputerowa tomografia osiowa (zabieg)
  • Tomografia komputerowa (CT).
  • Diagnostyczny skan CAT
  • Diagnostyczny typ usługi skanowania CAT

Undergo CT/PET

Inne nazwy:
  • Obrazowanie medyczne, pozytonowa tomografia emisyjna
  • ZWIERZAK DOMOWY
  • Skanowanie zwierzęcia
  • Skan pozytonowej tomografii emisyjnej
  • Pozytonowa emisyjna tomografia komputerowa
  • PT
  • Pozytronowa tomografia emisyjna (zabieg)
Eksperymentalny: Arm III (atezolizumab, bevacizumab, mFOLFOX6)

Patients receive atezolizumab IV over 30-60 minutes on day 1. Treatment repeats every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients also receive bevacizumab IV over 30-90 minutes on day 1, oxaliplatin IV over 2 hours on day 1 cycles 1-10, leucovorin calcium IV over 2 hours on day 1, and fluorouracil IV over 46-48 hours on day 1. Treatment with oxaliplatin repeats every 2 weeks for up to 10 cycles in the absence of disease progression or unacceptable toxicity. Treatment of bevacizumab, leucovorin calcium, and fluorouracil repeat every 2 weeks for up to 48 cycles in the absence of disease progression or unacceptable toxicity. Patients undergo CT with or without PET or MRI throughout the trial. Patients may also undergo collection of optional blood samples throughout the trial.

Ancillary studies

Inne nazwy:
  • Ocena jakości życia

Given IV

Inne nazwy:
  • Avastin
  • ABP 215
  • Anty-VEGF
  • Humanizowane przeciwciało monoklonalne anty-VEGF
  • Przeciwciało monoklonalne anty-VEGF SIBP04
  • Anty-VEGF rhuMAb
  • Bewacyzumab awwb
  • Bewacyzumab Biopodobny ABP 215
  • Bewacyzumab Biopodobny BEVZ92
  • Bevacizumab Biopodobny BI 695502
  • Bewacizumab Biopodobny CBT 124
  • Bewacyzumab Biopodobny CT-P16
  • Bewacyzumab Biopodobny FKB238
  • Bevacizumab Biopodobny GB-222
  • Bevacizumab Biopodobny HD204
  • Bevacizumab Biopodobny HLX04
  • Bewacyzumab Biopodobny IBI305
  • Bewacyzumab biopodobny LY01008
  • Bevacizumab Biopodobny MIL60
  • Bevacizumab Biopodobny Mvasi
  • Bevacizumab Biopodobny MYL-1402O
  • Bevacizumab Biopodobny QL 1101
  • Bewacyzumab Biopodobny RPH-001
  • Bewacizumab Biopodobny SCT501
  • Bevacizumab Biopodobny Zirabew
  • Bevacizumab-awwb
  • Bevacizumab-bvzr
  • BP102
  • BP102 Biopodobny
  • HD204
  • Immunoglobulina G1 (ludzko-mysi monoklonalny rhuMab-VEGF łańcuch gamma przeciwludzki czynnik wzrostu śródbłonka naczyniowego), dwusiarczek z ludzko-mysim monoklonalnym łańcuchem lekkim rhuMab-VEGF, dimer
  • Mvasi
  • MYL-1402O
  • Rekombinowane humanizowane przeciwciało monoklonalne anty-VEGF
  • rhuMab-VEGF
  • SCT501
  • SIP 04
  • SIBP-04
  • SIBP04
  • Zirabew
  • Avegra
  • QL1101
  • IBI305
  • Byvasda
  • Bewacyzumab Biopodobny QL1101
  • BAT1706
  • BAT 1706
  • BAT-1706
  • BAT1706 Biopodobny
  • Bewacizumab Biopodobny BAT1706
  • Bewacyzumab-adcd
  • CT-P16
  • Vegzelma
  • Alymsys
  • ABP-215
  • ABP215
  • Aybintio
  • Bewacyzumab-aybi
  • Odpowiednik bewacyzumabu
  • Bewacyzumab-maly
  • Bewacyzumab-onbe
  • CT P16
  • CTP16
  • Równy
  • Onbevzi
  • Avzivi
  • Bewacyzumab Biopodobny MB02
  • Bewacyzumab-tnjn
  • FKB 238
  • FKB-238
  • FKB238
  • MB 02
  • MB-02
  • MB02
  • Oyavas
  • PF 06439535
  • PF-06439535
  • PF06439535
  • Bevacizumab-aveg
  • Bevacizumab-byva
  • Bevacizumab-nwgd
  • Jobevne
  • IBI 305
  • IBI-305

Given IV

Inne nazwy:
  • 5-fluracyl
  • Fluracyl
  • 5 Fluorouracyl
  • 5 Fluorouracylum
  • 5 fu
  • 5-Fluoro-2,4(1H, 3H)-pirymidynodion
  • 5-fluorouracyl
  • 5-Fu
  • 5FU
  • AccuSite
  • Carac
  • Fluorouracyl
  • Fluouracyl
  • Flurablastyna
  • Fluracedyl
  • Fluril
  • Fluroblastyna
  • Rybofluor
  • Rz 2-9757
  • Ro-2-9757

Undergo MRI

Inne nazwy:
  • MRI
  • Rezonans magnetyczny
  • Skanowanie rezonansu magnetycznego
  • Obrazowanie medyczne, rezonans magnetyczny / jądrowy rezonans magnetyczny
  • PAN
  • Obrazowanie MR
  • Obrazowanie NMR
  • NMRI
  • Obrazowanie magnetycznego rezonansu jądrowego
  • Obrazowanie metodą rezonansu magnetycznego (MRI)
  • sMRI
  • Rezonans magnetyczny (zabieg)
  • Strukturalny MRI

Ancillary studies

Undergo collection of blood samples

Inne nazwy:
  • Pobieranie próbek biologicznych
  • Zebrano próbki biologiczne
  • Kolekcja próbek

Given IV

Inne nazwy:
  • Tecentrik
  • MPDL3280A
  • RO5541267
  • RG7446
  • MPDL 3280A
  • MPDL 328OA
  • MPDL-3280A
  • MPDL328OA
  • RG-7446
  • RO 5541267
  • RO-5541267

Given IV

Inne nazwy:
  • 1-OHP
  • Dakotyna
  • Dacplat
  • Eloksatyna
  • Ai Heng
  • Aiheng
  • Diaminocykloheksan Oxalatoplatinum
  • JM-83
  • Oksalatoplatyna
  • Szczawianoplatyna
  • 54780 RP
  • RP-54780
  • SR-96669
  • SR96669
  • Elplat
  • JM 83
  • JM83
  • RP54780
  • SR 96669

Undergo CT or CT/PET

Inne nazwy:
  • Tomografia komputerowa
  • KOT
  • Skanowanie CAT
  • Tomografia komputerowa osiowa
  • Komputerowa tomografia osiowa
  • tomografia
  • Komputerowa tomografia osiowa (zabieg)
  • Tomografia komputerowa (CT).
  • Diagnostyczny skan CAT
  • Diagnostyczny typ usługi skanowania CAT

Given IV

Inne nazwy:
  • Kwas foliowy

Undergo CT/PET

Inne nazwy:
  • Obrazowanie medyczne, pozytonowa tomografia emisyjna
  • ZWIERZAK DOMOWY
  • Skanowanie zwierzęcia
  • Skan pozytonowej tomografii emisyjnej
  • Pozytonowa emisyjna tomografia komputerowa
  • PT
  • Pozytronowa tomografia emisyjna (zabieg)

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Progression free survival (PFS)
Ramy czasowe: From the time from randomization until first confirmed progression or death from any cause, assessed up to 5 years

The analysis set is intent-to-treat (ITT). The experimental arms will be compared to the control arm by the log-rank test stratified by BRAF status (V600E mutation or not), metastatic disease: (liver-only, extra-hepatic), and prior adjuvant therapy for colon cancer (yes, no). Hazard ratios and associated confidence intervals from a stratified Cox regression model will also be reported along with estimates of the distributions of time to PFS event by the method of Kaplan and Meier. Sensitivity analyses accounting for 2 or more consecutively missed scheduled tumor imaging scans before progression/death will also be conducted.

From the time from randomization until first confirmed progression or death from any cause, assessed up to 5 years

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Wskaźnik PFS
Ramy czasowe: W wieku 12 miesięcy
W wieku 12 miesięcy
Overall survival (OS)
Ramy czasowe: The time from randomization to death from any cause, assessed up to 5 years

Will be analyzed using the stratified log rank test and the ITT population. Kaplan-Meier plots will illustrate the distribution of these endpoints by treatment. Stratified Cox regression models will be used to estimate hazard ratios and associated confidence intervals.

The time from randomization to death from any cause, assessed up to 5 years
Objective response rate (ORR) (complete response [CR] or partial response [PR])
Ramy czasowe: Up to 5 years

Assessed by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1. Will be analyzed by a logistic regression models that control for the stratification factors (BRAF status, liver involvement, and adjuvant chemotherapy [chemo]) using the ITT population. Observed proportions along with confidence intervals will be presented by treatment.

Up to 5 years
Incidence of adverse events
Ramy czasowe: Up to 30 days after last cycle

Defined by Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. The safety profile will be described by tabulating the maximum observed grade of adverse event for each individual adverse event, for each system organ class, and overall using the Safety population.

Up to 30 days after last cycle
Disease control rate (CR + PR + stable disease [SD])
Ramy czasowe: At 12 months

Assessed by RECIST 1.1. Will be analyzed by a logistic regression models that control for the stratification factors (BRAF status, liver involvement, and adjuvant chemo) using the ITT population. Observed proportions along with confidence intervals will be presented by treatment.

At 12 months
Duration of overall response (CR or PR)
Ramy czasowe: From the time of first response to first confirmed progression by the study investigator or death from any cause, assessed up to 5 years

Assessed by RECIST 1.1. Will be analyzed using the stratified log rank test and the ITT population. Kaplan-Meier plots will illustrate the distribution of these endpoints by treatment. Stratified Cox regression models will be used to estimate hazard ratios and associated confidence intervals.

From the time of first response to first confirmed progression by the study investigator or death from any cause, assessed up to 5 years
Duration of SD
Ramy czasowe: From the time of first on-study assessment of SD to first progression by the study investigator or death from any cause, assessed up to 5 years

Assessed per RECIST 1.1. Will be analyzed using the stratified log rank test and the ITT population. Kaplan-Meier plots will illustrate the distribution of these endpoints by treatment. Stratified Cox regression models will be used to estimate hazard ratios and associated confidence intervals.

From the time of first on-study assessment of SD to first progression by the study investigator or death from any cause, assessed up to 5 years

Inne miary wyników

Miara wyniku
Opis środka
Ramy czasowe
Severity of fatigue
Ramy czasowe: At 16 weeks

Will use the ITT population. Measured by the Patient Reported Outcomes Measurement Information System (PROMIS) Fatigue questionnaire. Will be compared between the control arm (Chemo-bevacizumab [Bev]) and the experimental arm by means of ordinal logistic regression with adjustment for the corresponding baseline measurement and stratification variables. The comparison will be performed at the significance level of 0.05 (two-sided) and the clinical meaningfulness of the comparison will be considered.

At 16 weeks
Physical functioning
Ramy czasowe: At 16 weeks

Will use the ITT population. Measured by the European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire (QLQ)-C30 physical functioning scale. Will be compared between the control arm (Chemo-Bev) and the experimental arm by means of ordinal logistic regression with adjustment for the corresponding baseline measurement and stratification variables. The comparison will be performed at the significance level of 0.05 (two-sided) and the clinical meaningfulness of the comparison will be considered.

At 16 weeks
Health utility scores
Ramy czasowe: Up to 5 years

Will use the ITT population. Will be measured using the EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) questionnaire.

Up to 5 years
Proportion of patients reporting each response option at each assessment timepoint by treatment arm for item GP5 from the Functional Assessment of Cancer Therapy - General (FACT-G)
Ramy czasowe: Up to 5 years

Will use the ITT population.

Up to 5 years
Intratumoral lymphocyte PD-L1+ expression (>= 1 % is positive) by immunohistochemistry (IHC) as a predictive biomarker of efficacy
Ramy czasowe: Up to 5 years

Will use the ITT population.

Up to 5 years
Efficacy dependent on the number of somatic mutations
Ramy czasowe: Up to 5 years

Will use the ITT population.

Up to 5 years
Efficacy in tumors with MLH1 silencing
Ramy czasowe: Up to 5 years

Will use the ITT population.

Up to 5 years
Change in quantification of cell free deoxyribonucleic acid (cfDNA) mutations
Ramy czasowe: Baseline up to 5 years

Will use the ITT population.

Baseline up to 5 years
Development of progression or relapse to treatment in cfDNA
Ramy czasowe: Up to 5 years

Will use the ITT population.

Up to 5 years
Changes in T-cell repertoire diversity as a predictive biomarker of efficacy
Ramy czasowe: Baseline up to 5 years

Will use the ITT population.

Baseline up to 5 years
PFS of patients with high levels of diversity
Ramy czasowe: Up to 5 years

Compared to patients with low levels of diversity. Will use the ITT population.

Up to 5 years
Change in T-cell diversity
Ramy czasowe: Baseline to first restaging between immunotherapy arms and the standard of care arm

Will use the ITT population.

Baseline to first restaging between immunotherapy arms and the standard of care arm
Mechanism of immune resistance to PD-1 blockade in mismatch repair deficient (dMMR)/microsatellite instability-high metastatic colorectal cancer (mCRC) by comparative analysis of tumor samples collected
Ramy czasowe: Baseline up to 5 years

Will use the ITT population.

Baseline up to 5 years

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Śledczy

  • Główny śledczy: Caio Max S Rocha Lima, NRG Oncology

Publikacje i pomocne linki

Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

19 stycznia 2018

Zakończenie podstawowe (Szacowany)

1 czerwca 2027

Ukończenie studiów (Szacowany)

1 czerwca 2027

Daty rejestracji na studia

Pierwszy przesłany

19 grudnia 2016

Pierwszy przesłany, który spełnia kryteria kontroli jakości

19 grudnia 2016

Pierwszy wysłany (Szacowany)

20 grudnia 2016

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

12 listopada 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

11 listopada 2026

Ostatnia weryfikacja

1 września 2026

Więcej informacji

Terminy związane z tym badaniem

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Tak

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj